US Stock MarketDetailed Quotes

Regencell Bioscience (RGC)

Watchlist
  • 20.450
  • +0.140+0.69%
Close Jun 10 16:00 ET
  • 20.450
  • 0.0000.00%
Pre 08:46 ET
10.13BMarket Cap-1460.71P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Regencell Bioscience (RGC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Dec 31, 2017
(Q4)Dec 31, 2017
(Q3)Sep 30, 2017
Total revenue
0
0
0
0
0
0
0
-1.07%3.16B
6.03%861.6M
-11.77%716M
Operating revenue
--0
--0
--0
--0
--0
--0
--0
-1.07%3.16B
6.03%861.6M
-11.77%716M
Cost of revenue
-2.87%1.19B
6.24%323.7M
-13.69%264.9M
Gross profit
0.06%1.97B
5.91%537.9M
-10.60%451.1M
Operating expense
-20.41%3.77M
-24.50%4.74M
-17.64%6.27M
451.47%7.62M
70.04%1.38M
107.77%812.37K
390.99K
4.22%1.7B
8.31%447.2M
2.68%428.6M
Selling and administrative expenses
-23.12%2.82M
-21.77%3.67M
-8.10%4.69M
441.40%5.11M
121.30%943.04K
161.81%426.14K
--162.77K
0.23%513.4M
0.23%128.8M
-0.70%126.9M
-Selling and marketing expense
-93.61%8.01K
-52.25%125.43K
939.22%262.66K
1,503.74%25.28K
-98.62%1.58K
3,039.28%114.21K
--3.64K
----
----
----
-General and administrative expense
-20.63%2.81M
-19.96%3.55M
-12.81%4.43M
439.62%5.08M
201.81%941.46K
96.03%311.93K
--159.13K
0.23%513.4M
0.23%128.8M
-0.70%126.9M
Research and development costs
-11.06%948.29K
-32.59%1.07M
-37.04%1.58M
473.13%2.51M
13.49%438.32K
69.23%386.23K
--228.22K
----
----
----
Depreciation amortization depletion
----
----
----
----
----
----
----
8.24%249.7M
6.54%63.5M
6.67%62.4M
-Depreciation and amortization
----
----
----
----
----
----
----
8.24%249.7M
6.54%63.5M
6.67%62.4M
Other operating expenses
----
----
----
----
----
----
----
3.33%912.6M
6.98%246.7M
0.49%227.4M
Operating profit
20.41%-3.77M
24.50%-4.74M
17.64%-6.27M
-451.47%-7.62M
-70.04%-1.38M
-107.77%-812.37K
-390.99K
-19.95%271.7M
-4.53%90.7M
-74.20%22.5M
Net non-operating interest income expense
2.34%-125.1M
-0.64%-31.6M
0.63%-31.7M
Other net income (expense)
-50.26%185.77K
76.73%373.51K
810.37%211.34K
-32.94%23.22K
34.62K
-4.40%67.3M
-49.75%10.1M
104.94%33.2M
Gain on sale of security
----
----
----
----
----
----
----
--17.8M
--0
--17.8M
Earnings from equity interest
----
----
----
----
----
----
----
-18.03%24.1M
25.89%-16.6M
-4.94%15.4M
Special income (charges)
----
----
----
----
----
----
----
-400.00%-24M
-241.38%-8.2M
-147.92%-11.9M
-Less:Impairment of capital assets
----
----
----
----
----
----
----
400.00%24M
241.38%8.2M
147.92%11.9M
-Less:Other special charges
----
----
----
----
----
----
----
--0
--0
--0
Other non- operating income (expenses)
-50.26%185.77K
76.73%373.51K
810.37%211.34K
-32.94%23.22K
--34.62K
----
----
----
----
----
Income before tax
17.85%-3.58M
28.03%-4.36M
20.18%-6.06M
-463.92%-7.59M
-65.78%-1.35M
-107.77%-812.37K
-390.99K
-24.07%213.9M
-17.32%69.2M
-66.43%24M
Income tax
0
0
0
0
0
0
0
-8.63%101.6M
35.23%40.3M
-56.85%12.6M
Net income
17.85%-3.58M
28.03%-4.36M
20.18%-6.06M
-463.92%-7.59M
-65.78%-1.35M
-107.77%-812.37K
-390.99K
-34.13%112.3M
-46.38%28.9M
-73.05%11.4M
Net income continuous Operations
17.85%-3.58M
28.03%-4.36M
20.18%-6.06M
-463.92%-7.59M
-65.78%-1.35M
-107.77%-812.37K
---390.99K
-34.13%112.3M
-46.38%28.9M
-73.05%11.4M
Minority interest income
0
67.90%-61.38K
-28.66%-191.2K
-148.61K
0
0
0
Net income attributable to the parent company
16.68%-3.58M
26.73%-4.3M
21.15%-5.87M
-452.88%-7.45M
-65.78%-1.35M
-107.77%-812.37K
-390.99K
-34.10%112.3M
-46.38%28.9M
-73.05%11.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.68%-3.58M
26.73%-4.3M
21.15%-5.87M
-452.88%-7.45M
-65.78%-1.35M
-107.77%-812.37K
-390.99K
-34.10%112.3M
-46.38%28.9M
-73.05%11.4M
Basic earnings per share
17.24%-0.0072
26.89%-0.0087
22.03%-0.0119
-444.52%-0.0153
-65.76%-0.0028
-107.74%-0.0017
-0.0008
-33.94%0.72
-44.12%0.19
-74.07%0.07
Diluted earnings per share
17.24%-0.0072
26.89%-0.0087
22.03%-0.0119
-444.52%-0.0153
-65.76%-0.0028
-107.74%-0.0017
-0.0008
-33.94%0.72
-44.12%0.19
-74.07%0.07
Dividend per share
0.00%0.88
0.00%0.22
0.00%0.22
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Jun 30, 2025(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019(FY)Dec 31, 2017(Q4)Dec 31, 2017(Q3)Sep 30, 2017
Total revenue 0000000-1.07%3.16B6.03%861.6M-11.77%716M
Operating revenue --0--0--0--0--0--0--0-1.07%3.16B6.03%861.6M-11.77%716M
Cost of revenue -2.87%1.19B6.24%323.7M-13.69%264.9M
Gross profit 0.06%1.97B5.91%537.9M-10.60%451.1M
Operating expense -20.41%3.77M-24.50%4.74M-17.64%6.27M451.47%7.62M70.04%1.38M107.77%812.37K390.99K4.22%1.7B8.31%447.2M2.68%428.6M
Selling and administrative expenses -23.12%2.82M-21.77%3.67M-8.10%4.69M441.40%5.11M121.30%943.04K161.81%426.14K--162.77K0.23%513.4M0.23%128.8M-0.70%126.9M
-Selling and marketing expense -93.61%8.01K-52.25%125.43K939.22%262.66K1,503.74%25.28K-98.62%1.58K3,039.28%114.21K--3.64K------------
-General and administrative expense -20.63%2.81M-19.96%3.55M-12.81%4.43M439.62%5.08M201.81%941.46K96.03%311.93K--159.13K0.23%513.4M0.23%128.8M-0.70%126.9M
Research and development costs -11.06%948.29K-32.59%1.07M-37.04%1.58M473.13%2.51M13.49%438.32K69.23%386.23K--228.22K------------
Depreciation amortization depletion ----------------------------8.24%249.7M6.54%63.5M6.67%62.4M
-Depreciation and amortization ----------------------------8.24%249.7M6.54%63.5M6.67%62.4M
Other operating expenses ----------------------------3.33%912.6M6.98%246.7M0.49%227.4M
Operating profit 20.41%-3.77M24.50%-4.74M17.64%-6.27M-451.47%-7.62M-70.04%-1.38M-107.77%-812.37K-390.99K-19.95%271.7M-4.53%90.7M-74.20%22.5M
Net non-operating interest income expense 2.34%-125.1M-0.64%-31.6M0.63%-31.7M
Other net income (expense) -50.26%185.77K76.73%373.51K810.37%211.34K-32.94%23.22K34.62K-4.40%67.3M-49.75%10.1M104.94%33.2M
Gain on sale of security ------------------------------17.8M--0--17.8M
Earnings from equity interest -----------------------------18.03%24.1M25.89%-16.6M-4.94%15.4M
Special income (charges) -----------------------------400.00%-24M-241.38%-8.2M-147.92%-11.9M
-Less:Impairment of capital assets ----------------------------400.00%24M241.38%8.2M147.92%11.9M
-Less:Other special charges ------------------------------0--0--0
Other non- operating income (expenses) -50.26%185.77K76.73%373.51K810.37%211.34K-32.94%23.22K--34.62K--------------------
Income before tax 17.85%-3.58M28.03%-4.36M20.18%-6.06M-463.92%-7.59M-65.78%-1.35M-107.77%-812.37K-390.99K-24.07%213.9M-17.32%69.2M-66.43%24M
Income tax 0000000-8.63%101.6M35.23%40.3M-56.85%12.6M
Net income 17.85%-3.58M28.03%-4.36M20.18%-6.06M-463.92%-7.59M-65.78%-1.35M-107.77%-812.37K-390.99K-34.13%112.3M-46.38%28.9M-73.05%11.4M
Net income continuous Operations 17.85%-3.58M28.03%-4.36M20.18%-6.06M-463.92%-7.59M-65.78%-1.35M-107.77%-812.37K---390.99K-34.13%112.3M-46.38%28.9M-73.05%11.4M
Minority interest income 067.90%-61.38K-28.66%-191.2K-148.61K000
Net income attributable to the parent company 16.68%-3.58M26.73%-4.3M21.15%-5.87M-452.88%-7.45M-65.78%-1.35M-107.77%-812.37K-390.99K-34.10%112.3M-46.38%28.9M-73.05%11.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.68%-3.58M26.73%-4.3M21.15%-5.87M-452.88%-7.45M-65.78%-1.35M-107.77%-812.37K-390.99K-34.10%112.3M-46.38%28.9M-73.05%11.4M
Basic earnings per share 17.24%-0.007226.89%-0.008722.03%-0.0119-444.52%-0.0153-65.76%-0.0028-107.74%-0.0017-0.0008-33.94%0.72-44.12%0.19-74.07%0.07
Diluted earnings per share 17.24%-0.007226.89%-0.008722.03%-0.0119-444.52%-0.0153-65.76%-0.0028-107.74%-0.0017-0.0008-33.94%0.72-44.12%0.19-74.07%0.07
Dividend per share 0.00%0.880.00%0.220.00%0.22
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.23%
Sample Name
Sample Code
 +1.31%
Sample Name
Sample Code
 -1.03%
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-2.32%
5
ProShares UltraShort Energy
DUG
-2.99%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +2.95%
Sample Name
Sample Code
 +1.98%
Sample Name
Sample Code
 +1.29%
4
Tencent Music
TME
+0.77%
5
Zai Lab
ZLAB
+0.52%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Tensions in the Middle East continue to escalate. Following Iran's downing of a U.S. Apache helicopter, American forces launched retaliatory Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -